These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 27446015)

  • 1. Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment.
    Pereyre S; Goret J; Bébéar C
    Front Microbiol; 2016; 7():974. PubMed ID: 27446015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycoplasma pneumoniae: susceptibility and resistance to antibiotics.
    Bébéar C; Pereyre S; Peuchant O
    Future Microbiol; 2011 Apr; 6(4):423-31. PubMed ID: 21526943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance.
    Cao B; Qu JX; Yin YD; Eldere JV
    Clin Respir J; 2017 Jul; 11(4):419-429. PubMed ID: 26365811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of drug resistance in Mycoplasma pneumoniae.
    Bébéar CM; Pereyre S
    Curr Drug Targets Infect Disord; 2005 Sep; 5(3):263-71. PubMed ID: 16181145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in the treatment of pediatric Mycoplasma pneumoniae pneumonia.
    Ding G; Zhang X; Vinturache A; van Rossum AMC; Yin Y; Zhang Y
    Eur J Pediatr; 2024 Jul; 183(7):3001-3011. PubMed ID: 38634891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis.
    Ahn JG; Cho HK; Li D; Choi M; Lee J; Eun BW; Jo DS; Park SE; Choi EH; Yang HJ; Kim KH
    BMC Infect Dis; 2021 Sep; 21(1):1003. PubMed ID: 34563128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.
    Lee H; Yun KW; Lee HJ; Choi EH
    Expert Rev Anti Infect Ther; 2018 Jan; 16(1):23-34. PubMed ID: 29212389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis.
    Peuchant O; Ménard A; Renaudin H; Morozumi M; Ubukata K; Bébéar CM; Pereyre S
    J Antimicrob Chemother; 2009 Jul; 64(1):52-8. PubMed ID: 19429926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrolide-resistant Mycoplasma pneumoniae pneumonia in transplantation: Increasingly typical?
    Eschenauer GA; Xiao L; Waites KB; Crabb DM; Ratliff AE; Gandhi TN; Riddell J; Kaul DR
    Transpl Infect Dis; 2020 Oct; 22(5):e13318. PubMed ID: 32386104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children.
    Okada T; Morozumi M; Tajima T; Hasegawa M; Sakata H; Ohnari S; Chiba N; Iwata S; Ubukata K
    Clin Infect Dis; 2012 Dec; 55(12):1642-9. PubMed ID: 22972867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility and genotyping of
    Zhao F; Liu J; Shi W; Huang F; Liu L; Zhao S; Zhang J
    Antimicrob Resist Infect Control; 2019; 8():18. PubMed ID: 30697421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killing kinetics of minocycline, doxycycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae.
    Morozumi M; Okada T; Tajima T; Ubukata K; Iwata S
    Int J Antimicrob Agents; 2017 Aug; 50(2):255-257. PubMed ID: 28579455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory pathogens: assessing resistance patterns in Europe and the potential role of grepafloxacin as treatment of patients with infections caused by these organisms.
    Felmingham D
    J Antimicrob Chemother; 2000 Mar; 45():1-8. PubMed ID: 10719006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical characteristics, treatment and outcome of macrolide-resistant Mycoplasma pneumoniae pneumonia in children].
    Bao F; Qu JX; Liu ZJ; Qin XG; Cao B
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):756-61. PubMed ID: 24433804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrolide-resistant Mycoplasma pneumoniae in adults in Zhejiang, China.
    Zhou Z; Li X; Chen X; Luo F; Pan C; Zheng X; Tan F
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1048-51. PubMed ID: 25451048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prevalence of
    Big Mohammadi H; Pouladi I; Zolfaghari MR; Niakan M
    Rep Biochem Mol Biol; 2020 Jul; 9(2):156-162. PubMed ID: 33178864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An adult case of severe life-threatening Mycoplasma pneumoniae pneumonia due to a macrolide-resistant strain, Japan: a case report.
    Matsumoto M; Nagaoka K; Suzuki M; Konno S; Takahashi K; Takashina T; Ishiguro N; Nishimura M
    BMC Infect Dis; 2019 Feb; 19(1):204. PubMed ID: 30819124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe.
    Critchley IA; Jones ME; Heinze PD; Hubbard D; Engler HD; Evangelista AT; Thornsberry C; Karlowsky JA; Sahm DF
    Clin Microbiol Infect; 2002 Apr; 8(4):214-21. PubMed ID: 12047413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates.
    Li X; Atkinson TP; Hagood J; Makris C; Duffy LB; Waites KB
    Pediatr Infect Dis J; 2009 Aug; 28(8):693-6. PubMed ID: 19633515
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Alishlash AS; Atkinson TP; Schlappi C; Leal SM; Waites KB; Xiao L
    Pediatrics; 2019 Oct; 144(4):. PubMed ID: 31488697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.